Hemolytic uremic syndrome

Active Research Protocols

  1. 06-C-0150 – A Phase II Clinical Trial of Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin for CD25 Positive Hairy Cell Leukemia
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014